Find Faculty
Charles A Powell, MD, MBA
img_Charles A Powell
DIRECTOR, MOUNT SINAI-NATIONAL JEWISH HEALTH RESPIRATORY INSTITUTE
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
email
Are you a patient?
View my
Provider Profile
Specialties
Pulmonary Medicine (Lung), Sleep Medicine
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET]
Lung adenocarcinoma can progress from an indolent in situ carcinoma to an invasive, aggressive, metastatic tumor. The WHO/IASLC/ATS Lung adenocarcinoma classification emphasizes the distinction of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma from their invasive counterparts.  Molecular biomarkers of invasion can distinguish invasive from non-invasive tumors, a distinction that is typically difficult to make in small biopsies and cytology specimens and is becoming increasingly important as the recognition of early stage adenocarcinoma increases with the widespread implementation of lung cancer screening programs in the United States. Please visit the Charles Powell Lab.

MD, University of Chicago Pritzker School of Medicine

Residency, Internal Medicine, Columbia Presbyterian Medical Center

Fellowship, Pulmonary and Critical Care Medicine, Boston University Medical Center

Certifications

American Board of Internal Medicine
164
Publications

Selected Publications

Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement. Seyed Javad Moghaddam, Rajkumar Savai, Ramin Salehi-Rad, Shreoshi Sengupta, Michael N. Kammer, Pierre Massion, Jennifer E. Beane, Edwin J. Ostrin, Carmen Priolo, Meredith A. Tennis, Laura P. Stabile, Alison K. Bauer, Catherine R. Sears, Eva Szabo, M. Patricia Rivera, Charles A. Powell, Humam Kadara, Brendan J. Jenkins, Steven M. Dubinett, A. Mc Garry Houghton, Carla F. Kim, Robert L. Keith. American Journal of Respiratory and Critical Care Medicine

Clinical and translational mode of single-cell measurements: An artificial intelligent single cell. Xiangdong Wang, Charles A. Powell, Qin Ma, Jia Fan. Clinical and Translational Discovery

Development and Validation of a Deep Learning Classifier Using Chest Radiographs to Predict Extubation Success in Patients Undergoing Invasive Mechanical Ventilation. Pranai Tandon, Kim Anh Nhi Nguyen, Masoud Edalati, Prathamesh Parchure, Ganesh Raut, David L. Reich, Robert Freeman, Matthew A. Levin, Prem Timsina, Charles A. Powell, Zahi A. Fayad, Arash Kia. Bioengineering

View All Publications

Charles Powell, MD

Annenberg Building Floor 5 Room 20

1468 Madison Ave

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Powell during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bristol-Myers Squibb
  • Duality Biologics
  • Astrazeneca
  • BioNTech
  • Clario
  • Daiichi Sankyo
  • Eisai, Inc.
  • Merus N.V.
  • Senwha Biosciences
  • Aptar
  • Seagen
  • Pfizer Inc., U.S. Pharmaceuticals Group

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.